BiliaryTractCancer near Sun City Center, FL

Care Philosophy: Dr Nicholas Figura is an Assistant Member in the Department of Radiation Oncology. Dr Figura will be located at the Moffitt partnership site at Morton Plant Hospital in Clearwater, working with Dr Ronica Nanda and Dr Roberto Diaz. Dr Figura received his MD from the University of South Florida, Morsani College of Medicine. He recently completed a Radiation Oncology Residency at Moffitt Cancer Center/University of South Florida, where he also served as Chief Resident. Dr Figura's clinical interests include the use of definitive radiotherapy in the treatment of head and neck, thoracic, gastrointestinal, and hematologic malignancies as well as the use of palliative radiotherapy for oligometastatic disease.

Care Philosophy: Her philosophy in caring for patients is to offer the least invasive, individualized yet comprehensive treatment options she would recommend for members of her own family. Her patients remain extremely important to her and she enjoys being able to help them return to happy, fulfilling lives. In her spare time, Dr Monteiro enjoys spending time with her family, traveling, and exercise.

Care Philosophy: Dr Amalia Stefanou is as an Assistant Member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. Dr Stefanou previously worked at Henry Ford Medical Group/Henry Ford Hospital and Wayne State University School of Medicine, where she achieved the rank of Assistant Professor. Dr Stefanou received her MD degree from Wayne State University School of Medicine, Detroit, Michigan, and she completed a Residency in General Surgery at Henry Ford Hospital, where she served as Chief Resident. Dr Stefanou then completed a Colon and Rectal Surgery Residency Training Program at Cook County Hospital/University of Illinois, Chicago.

Care Philosophy: At Tampa General Medical Group, we are committed to partnering with our patients to help them achieve their best health possible. We strive to provide high-quality, personalized, cost-effective care to our patients by listening to their medical concerns and encouraging their involvement in important decisions. Our board-certified internal medicine and family medicine physicians and pediatricians take pride in focusing on improved health through prevention and evidence-based care. Our goal is to empower our patients to advocate for their health.

Biography: Douglas E. Politz, MD, is one of the most experienced parathyroid surgeons in the world, having performed over 8,000 parathyroidectomies. He has dedicated his career to parathyroid disease, combining enormous experience with superior knowledge and skill to compliment his warm, engaging manner. Having seen the simplest and the most challenging parathyroid disease scenarios, Dr. Politz welcomes patients who have been diagnosed for the first time and those with prior attempts at surgical cure. Patients whose parathyroid disease is associated with thyroid cancer or kidney disease also benefit from his decades of experience. Dr. Politz has helped refine advanced techniques of minimally invasive parathyroidectomy used to quickly identify the four parathyroid glands in surgery. He has examined over 25,000 parathyroid glands and has helped train the most experienced handful of parathyroid surgeons worldwide who have followed him in this field. Dr. Politz has operated on patients from every U.S. state and multiple continents.

Care Philosophy: Dr Chatwal earned her MD at Florida State University School of Medicine. She completed her Internal Medicine Residency at Emory University School of Medicine, followed by a Hematology Oncology Fellowship at Moffitt Cancer Center and the University of South Florida Morsani College of Medicine. Dr Chatwal's clinical focus is the medical oncology management of patients with genitourinary malignancies, particularly prostate cancer. Her research focus is on prostate cancer clinical trials and outcomes. Dr Chatwal also has a practical and research interest in the important issue of provider burnout.

Care Philosophy: Dr Amod Sarnaik is a surgical oncologist in the Department of Cutaneous Oncology,the Immunology Program and the Melanoma Center of Excellence at Moffitt Cancer Center. In addition, Dr Sarnaik holds an appointmentof associate professor of oncology and surgery at the University of South Florida. Dr Sarnaik's primary research interest involves investigation of novel immunotherapeutic treatments for melanoma. This includes tumor-based vaccines, immune-activating antibodies, targeted inhibition of oncogenic proteins and autologous T-cell therapy. His clinical interests focus on the surgical treatment of melanoma and other cutaneous-based skin cancers, sentinel lymph node biopsy techniques, and minimizing surgically-related morbidities.

Care Philosophy: We work as a team to make sure that every patient receives the highest quality, most effective treatment available today. That's especially true for prostate cancer patients, where there are so many options. For us, treating prostate cancer is not only about curing the disease, but assuring each patient's long term quality of life. Toward that end, I establish open communications with my patients, for their ease of access and peace of mind from diagnosis through recovery.

Care Philosophy: At Moffitt Cancer Center we are working tirelessly in the areas of patient care research and education to advance one step further in fighting cancer As a National Cancer Institute designated Comprehensive Cancer Center we are committed to the health and safety of our patients and dedicated to providing expert cancer care From enhanced quality of life to complete remission Moffitt is Florida s top choice aiming to achieve the best outcome for each patient

Care Philosophy: Dr Chung's laboratory was among the first to recognize the importance of human papillomavirus (HPV) in the etiology of certain HNC as seen in one of the four subtypes in our molecular characterization study. Specifically the research showed that the most significantly deregulated genes in the HPV-positive tumors are cell cycle regulators. These data provided evidence that HPV-positive tumors may be more sensitive to chemotherapy and molecular inhibitors that specifically target cell cycle. In addition, her research findings contributed to establish the prognostic implication of the HPV status. Patients with HPV-positive HNC have a better prognosis compared to patients with HPV-negative HNC.

Biography: Dr. Puri received her MD degree from Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India. She completed an Internal Medicine Residency at the University of Connecticut School of Medicine, Farmington, followed by a Hematology and Oncology Fellowship at Moffitt Cancer Center, Tampa. Dr. Puri joins us from the Huntsman Cancer Institute at the University of Utah, Salt Lake City, where she was appointed Assistant Professor in the Division of Medical Oncology. During her time at the Huntsman Cancer Institute, she served as the Physician Leader for the Thoracic Clinical Trial Research Group; in that role, she managed the ongoing and future clinical trial portfolio. We are excited for her to partner with Dr. Andreas Saltos in the role of our Clinical Research Medical Director to drive the clinical research vision and manage our trial portfolio. Dr. Puri's clinical interests involve treating patients with thoracic malignancies including non-small cell and small cell lung cancer. Her research interests include development of clinical trials for patients with thoracic malignancies with emphasis on immunotherapy, targeted therapy, and other novel therapeutics.

Care Philosophy: "Creative Solutions to Complex Problems"

Care Philosophy: Dr Montejo joined the Moffitt Radiation Oncology Faculty in 2013 and currently serves as the departmental section head for the gynecologic radiation oncology service and radiation oncology service at Moffitt International Plaza satellite. His clinical interests include management of lymphoma, female gynecologic and breast malignancies including application of brachytherapy and modern highly conformal image-guided external beam radiotherapy. His research interests include brachytherapy and adaptation of highly conformal image-guided external body radiosurgery techniques to gynecologic and breast malignancy applications.

Care Philosophy: Dr Julian Sanchez is a colorectal surgeon in the Department of Gastrointestinal Oncology at Moffitt Cancer Center. He is Associate Professor of Surgery and Associate Professor of Oncologic Sciences at the University of South Florida Morsani College of Medicine. He is board certified in both general surgery and in colorectal surgery. Dr Sanchez's clinical interests include colon and rectal cancer, anal cancer, high resolution anoscopy, genetic cancer syndromes, and minimally invasive surgery. His research centers on HPV infection and associated anal cancer. He is especially interested in the progression of anal dysplasia in immunosuppression and in screening programs for high risk patients.

Care Philosophy: Dr Sameh Gaballa is an AssociateMember in the Moffitt Cancer Center Department of Malignant Hematology. Dr Gaballa earned his MD from Aims Shams University in Cairo, Egypt. He completed an Internal Medicine Residency and a Hematology and Medical Oncology Fellowship at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. He then completed a Stem Cell Transplantation and Cellular Therapy Fellowship at the University of Texas MD Anderson Cancer Center. Dr Gaballa previously practiced in the Thomas Jefferson University, Division of Hematologic Malignancies and Blood and Marrow Transplantation.